105 related articles for article (PubMed ID: 28668446)
1. Influenza vaccine effectiveness in adults based on the rapid influenza diagnostic test results, during the 2015/16 season.
Seki Y; Onose A; Sugaya N
J Infect Chemother; 2017 Sep; 23(9):615-620. PubMed ID: 28668446
[TBL] [Abstract][Full Text] [Related]
2. Three-season effectiveness of inactivated influenza vaccine in preventing influenza illness and hospitalization in children in Japan, 2013-2016.
Sugaya N; Shinjoh M; Nakata Y; Tsunematsu K; Yamaguchi Y; Komiyama O; Takahashi H; Mitamura K; Narabayashi A; Takahashi T;
Vaccine; 2018 Feb; 36(8):1063-1071. PubMed ID: 29361343
[TBL] [Abstract][Full Text] [Related]
3. Estimation of the Effectiveness of Quadrivalent Influenza Vaccines by Distinguishing Between Influenza A (H1N1) pdm09 and Influenza A (H3N2) Using Rapid Influenza Diagnostic Tests During the 2018-2019 Season.
Ando S
Intern Med; 2020 Apr; 59(7):933-940. PubMed ID: 31787695
[TBL] [Abstract][Full Text] [Related]
4. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
[TBL] [Abstract][Full Text] [Related]
5. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F;
Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Trivalent Inactivated Influenza Vaccine in Children Estimated by a Test-Negative Case-Control Design Study Based on Influenza Rapid Diagnostic Test Results.
Shinjoh M; Sugaya N; Yamaguchi Y; Tomidokoro Y; Sekiguchi S; Mitamura K; Fujino M; Shiro H; Komiyama O; Taguchi N; Nakata Y; Yoshida N; Narabayashi A; Myokai M; Sato M; Furuichi M; Baba H; Fujita H; Sato A; Ookawara I; Tsunematsu K; Yoshida M; Kono M; Tanaka F; Kawakami C; Kimiya T; Takahashi T; Iwata S;
PLoS One; 2015; 10(8):e0136539. PubMed ID: 26317334
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results.
Pebody R; Warburton F; Ellis J; Andrews N; Potts A; Cottrell S; Johnston J; Reynolds A; Gunson R; Thompson C; Galiano M; Robertson C; Byford R; Gallagher N; Sinnathamby M; Yonova I; Pathirannehelage S; Donati M; Moore C; de Lusignan S; McMenamin J; Zambon M
Euro Surveill; 2016 Sep; 21(38):. PubMed ID: 27684603
[TBL] [Abstract][Full Text] [Related]
8. Influenza vaccine showed a good preventive effect against influenza-associated hospitalization among elderly patients, during the 2016/17 season in Japan.
Seki Y; Onose A; Murayama T; Koide C; Sugaya N
J Infect Chemother; 2018 Nov; 24(11):873-880. PubMed ID: 30100400
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of quadrivalent influenza vaccine based on the test-negative control study in children during the 2016-2017 season.
Ando S
J Infect Chemother; 2018 Oct; 24(10):782-788. PubMed ID: 29945763
[TBL] [Abstract][Full Text] [Related]
10. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
[TBL] [Abstract][Full Text] [Related]
11. Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study.
Lytras T; Kossyvakis A; Melidou A; Andreopoulou A; Exindari M; Gioula G; Kalliaropoulos A; Tryfinopoulou K; Pogka V; Spala G; Malisiovas N; Mentis A
J Med Virol; 2016 Nov; 88(11):1896-904. PubMed ID: 27088266
[TBL] [Abstract][Full Text] [Related]
12. Inactivated influenza vaccine effectiveness and an analysis of repeated vaccination for children during the 2016/17 season.
Shinjoh M; Sugaya N; Yamaguchi Y; Iibuchi N; Kamimaki I; Goto A; Kobayashi H; Kobayashi Y; Shibata M; Tamaoka S; Nakata Y; Narabayashi A; Nishida M; Hirano Y; Munenaga T; Morita K; Mitamura K; Takahashi T;
Vaccine; 2018 Sep; 36(37):5510-5518. PubMed ID: 30093289
[TBL] [Abstract][Full Text] [Related]
13. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.
Martínez-Baz I; Navascués A; Pozo F; Chamorro J; Albeniz E; Casado I; Reina G; Cenoz MG; Ezpeleta C; Castilla J;
Hum Vaccin Immunother; 2015; 11(7):1626-33. PubMed ID: 25996366
[TBL] [Abstract][Full Text] [Related]
14. Trivalent inactivated influenza vaccine effective against influenza A(H3N2) variant viruses in children during the 2014/15 season, Japan.
Sugaya N; Shinjoh M; Kawakami C; Yamaguchi Y; Yoshida M; Baba H; Ishikawa M; Kono M; Sekiguchi S; Kimiya T; Mitamura K; Fujino M; Komiyama O; Yoshida N; Tsunematsu K; Narabayashi A; Nakata Y; Sato A; Taguchi N; Fujita H; Toki M; Myokai M; Ookawara I; Takahashi T
Euro Surveill; 2016 Oct; 21(42):. PubMed ID: 27784529
[TBL] [Abstract][Full Text] [Related]
15. Influenza vaccine effectiveness in adults 65 years and older, Denmark, 2015/16 - a rapid epidemiological and virological assessment.
Emborg HD; Krause TG; Nielsen L; Thomsen MK; Christiansen CB; Skov MN; Nielsen XC; Weinreich LS; Fischer TK; Rønn J; Trebbien R
Euro Surveill; 2016; 21(14):. PubMed ID: 27101732
[TBL] [Abstract][Full Text] [Related]
16. High performance of rapid influenza diagnostic test and variable effectiveness of influenza vaccines in Mexico.
Castillejos M; Cabello-Gutiérrez C; Alberto Choreño-Parra J; Hernández V; Romo J; Hernández-Sánchez F; Martínez D; Hernández A; Jiménez-Álvarez L; Hernández-Cardenas CM; Becerril-Vargas E; Martínez-Orozco JA; Luis Sandoval-Gutiérrez J; Guadarrama C; Olvera-Masetto E; Alfaro-Ramos L; Cruz-Lagunas A; Ramírez G; Márquez E; Pimentel L; Regino-Zamarripa NE; Mendoza-Milla C; Goodina A; Hernández-Montiel E; Barquera R; Santibañez A; Domínguez-Cherit G; Pérez-Padilla R; Regalado J; Santillán-Doherty P; Salas-Hernández J; Zúñiga J
Int J Infect Dis; 2019 Dec; 89():87-95. PubMed ID: 31493523
[TBL] [Abstract][Full Text] [Related]
17. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
[TBL] [Abstract][Full Text] [Related]
18. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
Skowronski DM; Janjua NZ; Sabaiduc S; De Serres G; Winter AL; Gubbay JB; Dickinson JA; Fonseca K; Charest H; Bastien N; Li Y; Kwindt TL; Mahmud SM; Van Caeseele P; Krajden M; Petric M
J Infect Dis; 2014 Jul; 210(1):126-37. PubMed ID: 24446529
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.
Belongia EA; Kieke BA; Donahue JG; Greenlee RT; Balish A; Foust A; Lindstrom S; Shay DK;
J Infect Dis; 2009 Jan; 199(2):159-67. PubMed ID: 19086915
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season.
McLean HQ; Caspard H; Griffin MR; Poehling KA; Gaglani M; Belongia EA; Talbot HK; Peters TR; Murthy K; Ambrose CS
Vaccine; 2017 May; 35(20):2685-2693. PubMed ID: 28408121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
